The AI Revolution in Hearing Health: Smarter Tech, Greater Access
Friday, June 12 | 10 a.m. EST
Artificial intelligence (AI) is poised to transform nearly every aspect of hearing health care, from screening and diagnosis to treatment and rehabilitation. In the near term, one of the most significant advances is the use of AI in hearing aids to address the long-standing challenge of understanding speech in noisy environments.
Our expert panelists will provide an overview of AI, with a particular focus on its expanding use in hearing aids. They will next turn to future global possibilities, especially for low-income and under-resourced settings. Can AI be leveraged to promote screening and diagnosis of common causes of hearing loss? What would it take to extend hearing health care to all? Join us for this thought-provoking panel discussion.
Still need to register for HLAA 2026?
Get pre-registration rates through May 18. The Research Symposium is included in full access, Friday one-day pass or as an individual event for $25.
Moderator:
Jan Blustein, M.D., Ph.D.
Dr. Jan Blustein is research professor of medicine and population health at New York University’s Grossman School of Medicine. Her research on hearing loss spans a range of topics, including the way we communicate about disability, and the influence of hearing loss on patient-physician communication. She serves as a professional adviser to HLAA and is also a past board member.
Panelists:
Nicholas Lesica, Ph.D.
Dr. Nicholas Lesica is a bioengineer who studies how the brain encodes external sensory input. He is a professor of neuroengineering in the Ear Institute at University College London (UCL), where his lab studies the neurophysiology of hearing and hearing loss. Dr. Lesica is also co-founder of a biotech start-up, Perceptual Technologies, which is using that research to develop deep learning algorithms that could lead to more advanced and effective hearing aids.
Cole Morris
Cole Morris is the co-founder and COO of Fortell Research Inc. Over the past five years, Fortell developed a hearing aid that uses custom chip technology and novel AI techniques to improve listening in noise. He was the principal investigator and co-author of Fortell’s first two clinical studies.
Samantha Kleindienst Robler, Au.D., Ph.D.
Dr. Robler is an audiology clinician scientist who develops novel tools and evidence-based strategies to improve accessibility of hearing healthcare. A nationally recognized expert in telehealth technologies, she studies innovative models of care to increase access in rural and underserved communities. Dr. Robler is an assistant professor at the University of Arkansas for Medical Sciences (UAMS) and associate director of the school’s Center for Hearing Health Access in Little Rock, Arkansas.
*HLAA’s Research Symposia is supported, in part, by a grant from the National Institute on Deafness and Other Communication Disorders, National Institutes of Health (Award Number R13DC017913).